Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-09

FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for sevelamer hydrochloride (Renagel) submitted by Sanofi-Aventis U.S. LLC. The approval updates the product labeling an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Renagel (sevelamer)

Snippet

SUPPL AP for SEVELAMER HYDROCHLORIDE (SEVELAMER HYDROCHLORIDE)